FDA’s Office of Generic Drugs issued their 2022 Annual Report. Generic drugs play a vital role in saving patients and payers money. To give an example, pregabalin capsules cost $450 for a 30-day supply during the end of its market exclusivity period, but priced dropped to $23 (a 95% decrease) during the first 12 months after generic entry. For this drug alone, savings to the healthcare system was $6.6 billion. experienced a 95% price reduction during the first 12 months of generic sales.
In 2022, the Office of Generic Drugs approved 106 first generic drugs. Below are some highlights from the report.